Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New phase III data on the efficacy of fesoterodine in OAB

April 20, 2005

SPI-153 enters phase II trial for BPH

April 18, 2005

5-HT2C agonists evaluated as therapeutics for urinary disorders

April 15, 2005

Toray and Takeda to jointly develop compound for frequent urination

April 11, 2005

Recent Roche patents describe therapeutic agents for genitourinary disorders

April 7, 2005

Dong-A PharmTech files IND for new PDE5 inhibitor for erectile dysfunction

April 1, 2005

Keryx finalizes SPA agreement for KRX-101

March 31, 2005

NX-1207 shows promise for BPH

March 29, 2005

PT-141 reported to increase the efficacy of sildenafil in ED

March 24, 2005

The STAR study confirms the greater efficacy of solifenacin in OAB

March 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...